OTC : MLSPF
$0.25 (3.82%)
| Source | Headline |
|---|---|
|
Melrose Industries PLC (MLSPF) Q2 2026 Earnings Call Transcript
Melrose Industries PLC (MLSPF) Q2 2026 Earnings Call Transcript seekingalpha.com - 2026-07-31 22:43:10 |
|
Melrose Industries H1 Earnings Call Highlights
Melrose Industries LON: MRO reported double-digit revenue and operating-profit growth for the first half of 2026, supported by demand in civil aerospace and defense, while an incident at its Garden Grove facility in California created uncertainty around production timing, exceptional costs and shareholder returns. marketbeat.com - 2026-07-31 06:06:02 |
|
Melrose shares fall 3.5% as Garden Grove incident drives £30m exceptional cost outlook
Melrose Industries PLC (LSE:MRO, OTC:MLSPF) shares fell 3.5% to 458.8p after the aerospace and defence group warned of further exceptional costs linked to a... proactiveinvestors.com - 2026-07-31 05:29:00 |
|
Melrose shares fall 3.5% as Garden Grove incident drives £30m exceptional cost outlook
Melrose Industries PLC (LSE:MRO, OTC:MLSPF) shares fell 3.5% to 458.8p after the aerospace and defence group warned of further exceptional costs linked to a chemical tank incident at its Garden Grove facility in the US. The company said it expects to incur additional exceptional costs of between £25 million and £30 million in the second half of 2026 as it continues its response to the incident, including regulatory and legal processes. proactiveinvestors.co.uk - 2026-07-31 04:37:45 |
|
Futura Medical gets greenlight for stronger product "Eroxon Intense"
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) said its stronger Eroxon Intense erectile dysfunction gel has been cleared for launch across the European... proactiveinvestors.com - 2026-07-31 03:42:00 |
|
BofA backs Melrose Industries with shares near year low
Bank of America has reiterated its 'buy' rating and 720p price target on Melrose Industries PLC (LSE:MRO, OTC:MLSPF), the FTSE 100 aerospace group, arguing the shares look cheap as they trade close to their lowest level this year. Melrose, which owns the GKN Aerospace engineering business, is due to report half-year results with its stock near a 12-month low. proactiveinvestors.co.uk - 2026-06-18 10:37:39 |
|
Melrose Industries: The Market Is Pricing In An Aerospace Growth Failure
Melrose Industries remains a Strong Buy after a 20% price decline, as operational performance and aerospace demand remain robust despite negative sentiment. MLSPF's Engines segment drives strong growth and margin expansion, with 11% revenue growth and a trajectory toward 25% margins and £600 million free cash flow. Current valuation reflects a 56% discount to peers and a 30% discount to growth, with 53–82% upside to $9.38–$11.14 price targets based on conservative assumptions. seekingalpha.com - 2026-06-11 16:36:42 |
|
Explosion fears at Melrose's GKN Aerospace plant trigger evacuation of 50,000 California residents
Shares in Melrose Industries PLC (LSE:MRO, OTC:MLSPF) fell as much 7% after a chemical incident at a GKN Aerospace facility in California triggered mass... proactiveinvestors.com - 2026-05-26 03:42:00 |
|
Explosion fears at Melrose's GKN Aerospace plant trigger evacuation of 50,000 California residents
Melrose Industries PLC (LSE:MRO, OTC:MLSPF) sought to reassure investors after a chemical incident at a GKN Aerospace facility in California triggered mass evacuations and warnings from emergency crews that a storage tank risked exploding. Authorities said the wider crisis was not yet over, however, warning there remained a risk of a smaller explosion or chemical leak. proactiveinvestors.co.uk - 2026-05-26 02:49:23 |